Abstract
AbstractChagas disease is an important disease affecting millions of patients in the New World and is caused by a protozoan transmitted by haematophagous kissing bugs. It can be treated with drugs during the early acute phase; however, effective therapy against the chronic form of Chagas disease has yet to be discovered and developed. We herein tested the activity of solenopsin alkaloids extracted from two species of fire ants against the protozoan parasite Trypanosoma cruzi, the aetiologic agent of Chagas disease. Although IC50 determinations showed that solenopsins are more toxic to the parasite than benznidazole, the drug of choice for Chagas disease treatment, the ant alkaloids presented a lower selectivity index. As a result of exposure to the alkaloids, the parasites became swollen and rounded in shape, with hypertrophied contractile vacuoles and intense cytoplasmic vacuolization, possibly resulting in osmotic stress; no accumulation of multiple kinetoplasts and/or nuclei was detected. Overexpressing phosphatidylinositol 3-kinase—an enzyme essential for osmoregulation that is a known target of solenopsins in mammalian cells—did not prevent swelling and vacuolization, nor did it counteract the toxic effects of alkaloids on the parasites. Additional experimental results suggested that solenopsins induced a type of autophagic and programmed cell death in T. cruzi. Solenopsins also reduced the intracellular proliferation of T. cruzi amastigotes in infected macrophages in a concentration-dependent manner and demonstrated activity against Trypanosoma brucei rhodesiense bloodstream forms, which is another important aetiological kinetoplastid parasite. The results suggest the potential of solenopsins as novel natural drugs against neglected parasitic diseases caused by kinetoplastids.
Publisher
Springer Science and Business Media LLC
Reference90 articles.
1. Aniszewski, T. Alkaloids: Chemistry, Biology, Ecology and Applications Vol. 2, 1–496 (Elsevier Science, Amsterdam, 2015).
2. Qiu, S. et al. Natural alkaloids: basic aspects, biological roles, and future perspectives. Chin. J. Nat. Med. 12, 401–406 (2014).
3. Cushnie, T. P. T., Cushnie, B. & Lamb, A. J. Alkaloids: an overview of their antibacterial, antibiotic-enhancing and antivirulence activities. Int. J. Antimicrob. Agents 44, 377–386 (2014).
4. Amirkia, V. & Heinrich, M. Alkaloids as drug leads—a predictive structural and biodiversity-based analysis. Phytochem. Lett. 10, 47–53 (2014).
5. Roberts, M. F. & Wink, M. Alkaloids: Biochemistry, Ecology and Medicinal (Plenum Press, New York, 1998).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献